Non-Amplification ERBB2 Genomic Alterations in 5,605 Cases of Relapsed and Metastatic Breast Cancer: an Emerging Opportunity for anti-HER2 Targeted Therapies - Ross, J S; Gay, L M; Wang, K (Cancer, 2016)
et al.